Track the 딥노이드 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 딥노이드 has logged 41 insider filings. Market capitalisation: €66.8bn. The latest transaction was filed on 21 May 2026 (Other). Among the most active insiders: 최우식. Every trade is accessible without an account.
41
Insider Decl.
0
Thresholds
·
16 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,220 of 26,270 companies
26.9
score / 100
Value
10
Quality
44
FCF yld-18%
Earn yld-26%
EV/EBITDA·
ROE-55%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.